Faron Pharmaceuticals Oy (LON:FARN - Get Free Report) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 207.36 ($2.78) and traded as high as GBX 227.80 ($3.05). Faron Pharmaceuticals Oy shares last traded at GBX 212.50 ($2.85), with a volume of 13,847 shares traded.
Faron Pharmaceuticals Oy Stock Up 7.6%
The company has a 50 day simple moving average of GBX 209.87 and a two-hundred day simple moving average of GBX 186.90. The company has a quick ratio of 1.09, a current ratio of 1.45 and a debt-to-equity ratio of 922.55. The company has a market capitalization of £322.20 million, a P/E ratio of -6.42 and a beta of 0.36.
Faron Pharmaceuticals Oy Company Profile
(
Get Free Report)
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Further Reading
Before you consider Faron Pharmaceuticals Oy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Faron Pharmaceuticals Oy wasn't on the list.
While Faron Pharmaceuticals Oy currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
